StockData
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. (WHWK) stock

WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.08+0.07 (+2.33%)

Close on Nov 17, 2026Market cap $175.59MP/E –Yield –

Whitehawk Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Whitehawk Therapeutics's enterprise value was -$5.29M on Nov 11, 2026, against -$52.32M a year earlier. Over the last 5 years it ranged from -$152.03M to $342.96M, with a median of $9.71M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$5.29M–
2025Dec 31, 2025-$48.55M-422.4%
2024Dec 31, 2024$15.06M–
2023Dec 29, 2023-$69.76M-153.7%
2022Dec 30, 2022$129.99M-62.1%
2021Dec 31, 2021$342.96M–
2020Dec 31, 2020-$5.73M–
2019Dec 31, 2019-$20.61M–
2018Dec 31, 2018-$6.71M-107.4%
2017Dec 29, 2017$90.84M–
2011Mar 28, 2011-$26.45K–

More Whitehawk Therapeutics figures

See a number that looks wrong?